Professor Mark Bellis is the Director of Policy, Research and International Development for Public Health Wales and Professor of Public Health at Bangor University.
Mark is the Head of the World Health Organization Collaborating Centre on Investment for Health and Well-being and a member of the WHO global expert advisory panel on violence prevention. Mark has undertaken substantive work in the fields of violence prevention, alcohol, drugs and sexual health. As well as international work with WHO, Professor Bellis has also worked as an advisor to organisations including; United Nations Development Programme, United Nations Office on Drugs and Crime and United Nations International Children's Emergency Fund. He has published over 170 academic papers and more than 250 applied public health reports and continues to direct an on-going research programme examining the prevention of violence and its impact on health across the life course.
Paul has been working in alcohol and other drug field for over 25 years and has worked in the club health area for much of that time.
He has been involved in a wide range of research projects investigating the use of ecstasy, ketamine and GHB and was an investigator on a WHO study examining cocaine use in Australia. He has developed and trialed a UNODC Global Youth Training Workshop preventing amphetamine type stimulants among young people. DARTA provides training to a wide range of audiences as well as develop resources, many of which deal with nightlife issues.
Karen is Research and Capacity Development Manager (Specialist Projects) at Public Health Wales and an Honorary Professor at Bangor University.
Karen has a broad public health research portfolio with focus on violence prevention, alcohol use, youth risk behaviours and nightlife health. She is a member of the global Violence Prevention Alliance and has acted as an expert advisor to organisations including the World Health Organization, European Monitoring Centre for Drugs and Drug Addiction, Department of Health and National Institute for Health Research. Karen has published over 80 academic papers and a wide range of national and international reports to inform public health policy and practice.
Stefanie Jones is director of audience development at the Drug Policy Alliance, a national advocacy nonprofit.
In this role she oversees development of communications, outreach and programs targeted to communities with explicit connections to drug use that have not historically been engaged in drug policy reform efforts. She runs DPA’s Safer Partying campaign, which introduces harm reduction principles and drug policy alternatives to partygoers, public health officials and city nightlife regulators across the United States. She also supervises the Safety First program manager, who coordinates DPA’s work developing Safety First, a harm reduction-based drug education curriculum for teens. Stefanie is based in New York.
Matej Košir is the Director of UTRIP.
He has been working in the field of addiction prevention and drug-related policy for the last 20 years. He is an author, co-author and reviewer of scientific articles and papers, and external evaluator of EC-funded projects in the field of health and research. He is a lecturer and facilitator of trainings and workshops in the field of prevention and advocacy. He has been a Postgraduate Research Assistant at Oxford Brookes University (UK) in the period of 2015-2016. He is a coordinator of the Prevention Platform network, which includes more than 40 supporting institutions and organisations (mostly NGOs) in Slovenia. He is also a senior consultant of the World Bank Group in the field of alcohol policy and prevention since January 2017. The European Society has awarded Matej for Prevention Research (EUSPR) with ‘Leading European Prevention Science Practitioner Honour’ in 2017.
João Matias is an epidemiologist, graduated from the London School of Hygiene and Tropical Medicine (LSHTM).
In 2004, he joined the European Monitoring Centre for Drugs and Drug Addiction. He works in the Public Health Unit as a scientific analyst on drug use, responsible for the epidemiological indicator ‚Prevalence and patterns of drug use‘, covering topics like drug use in nightlife settings, drug checking, wastewater and the European Web Survey on Drugs. He has also worked at the United Nations Office on Drugs and Crime (UNODC) as an analyst on drug markets.
Sarah is Director of the Community Partnership Drugs Programme in the School of Social Policy, Social Work and Social Justice in University College Dublin.
She holds a Ph.D. from the Centre for Action Research in Professional Practice, University of Bath. Dr Morton has extensive experience in policy, practice and outcome evaluation in relation to addressing complex social issues including drug and alcohol use. In recent years, she has focused on the interplay of violence and substance use and on innovation in substance use interventions for individuals, families and communities.
Zara is a Reader in Behavioural Epidemiology at the Public Health Institute, Liverpool John Moores University.
She has worked on nightlife-related research for 15 years, examining risky alcohol consumption (including preloading) and associated harms. Her research has informed the development of prevention activity across various UK nightlife settings, including: the development of nightlife worker training on identifying and preventing sexual violence; implementation of community based multi-component approaches (i.e. Drink Less Enjoy More) to preventing sales of alcohol to drunks patrons and alcohol-related harms; and interventions targeted towards addressing excessive student alcohol consumption. She is currently working on two European projects examining the translation of the STAD (Stockholm Prevents Alcohol and Drugs) model across various drinking settings in Europe, and the development and impact of nightlife worker training on preventing sexual violence.
Adam is a Consultant Addiction Psychiatrist at the South London and Maudsley NHS Trust and Honorary Senior Lecturer at the Institute of Psychiatry, Kings College London.
He has spent over a decade researching new trends, focusing on their patterns of use, effect profiles and predictors of harm. He has also monitored the impact of legislation on their use. He has written over 100 papers, monographs and book chapters. He is interested in helping to craft optimal public health responses to drugs and had written papers considering alternatives to criminalization as a means of legislative control. Adam is also founder and director of Global Drug Survey and architect of the drugs meter.